The OPERA study, conducted by ADSCC, aims to evaluate the safety and efficacy of Extracorporeal Photopheresis (ECP) as a potential treatment for type 1 diabetes mellitus (T1DM).
ADSCC has developed a clinical trial for the treatment of Multiple Sclerosis (MS). The PHOMS Study is a randomized, controlled, open-label assessment, centered on the safety and efficacy of Extracorporeal Photopheresis (ECP) in treating MS.
Dedicated to advancing medical research, ADSCC takes a leading role in fostering innovation in healthcare.
Since inception in 2018, ADSCC has been a beacon of progress dedicated to pioneering advancements in stem cell research and healthcare solutions.
In addition to the myriad publications, ADSCC houses a comprehensive collection of abstracts encapsulating the wealth of knowledge generated by our researchers.
Contact our clinical trials team to learn about current studies and whether you may be eligible to take part.
Mahdar Qutouf Street, Rowdhat, Abu Dhabi, UAE
Near Al Rawafed Pvt. School - Mhanna St - Khalifa City - SE44 - Abu Dhabi, UAE
Dalma Mall, Musaffah, First Floor
© 2026. All Rights Reserved.